Back to 
Parallax Volatility Advisers, L.P.
Parallax Volatility Advisers, L.P.
MCRB
Showing 0 of 7 quarters
Position history for Parallax Volatility Advisers, L.P.'s holdings in Seres Therapeutics, Inc.
No. Parallax Volatility Advisers exited its MCRB (Seres Therapeutics) position in Q1 2024. Its Q4 2023 13F listed 43,163 shares worth $60,428. Parallax Volatility Advisers first reported MCRB in Q2 2022 and held it in 5 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.